Evidence map›Paper›PMID 22969208›Full record

ArticleWorld journal of gastroenterology2012

Development of a quantum-dot-labelled magnetic immunoassay method for circulating colorectal cancer cell detection.

Maria Gazouli, Anna Lyberopoulou, Pericles Pericleous, Spyros Rizos, Gerassimos Aravantinos, Nikolaos Nikiteas, Nicholas P Anagnou, Efstathios P Efstathopoulos

Open access · hybridAbstract readEvaluation Study
In one paragraph

Article in World journal of gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Clinical significance of circulating tumour cells and tumour marker detection in the chemotherapeutic evaluation of advanced colorectal cancer.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2022
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Maria GazouliDepartment of Basic Medical Sciences, Laboratory of Biology, School of Medicine, University of Athens, 11527 Athens, Greece. mgazouli@med.uoa.gr
Anna Lyberopoulou
Pericles Pericleous
Spyros Rizos
Gerassimos Aravantinos
Nikolaos Nikiteas
Nicholas P Anagnou
Efstathios P Efstathopoulos
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo detect of colorectal cancer (CRC) circulating tumour cells (CTCs) surface antigens, we present an assay incorporating cadmium selenide quantum dots (QDs) in these paper.

methodsThe principle of the assay is the immunomagnetic separation of CTCs from body fluids in conjunction with QDs, using specific antibody biomarkers: epithelial cell adhesion molecule antibody, and monoclonal cytokeratin 19 antibody. The detection signal was acquired from the fluorescence signal of QDs. For the evaluation of the performance, the method under study was used to isolate the human colon adenocarcinoma cell line (DLD-1) and CTCs from CRC patients' peripheral blood.

resultsThe minimum detection limit of the assay was defined to 10 DLD-1 CRC cells/mL as fluorescence was measured with a spectrofluorometer. Fluorescence-activated cell sorting analysis and Real Time RT-PCR, they both have also been used to evaluate the performance of the described method. In conclusion, we developed a simple, sensitive, efficient and of lower cost (than the existing ones) method for the detection of CRC CTCs in human samples. We have accomplished these results by using magnetic bead isolation and subsequent QD fluorescence detection.

conclusionThe method described here can be easily adjusted for any other protein target of either the CTC or the host.

Indexed as

Quantum DotsAdenocarcinomaAntibodiesAntigens, NeoplasmCase-Control StudiesCell Adhesion MoleculesColorectal NeoplasmsEpithelial Cell Adhesion MoleculeHumansImmunoassayImmunomagnetic SeparationKeratin-19Sensitivity and SpecificitySpectrometry, FluorescenceAntibodiesAntigens, NeoplasmCell Adhesion MoleculesEpithelial Cell Adhesion MoleculeKeratin-19CancerCirculating tumor cellsMicrometastasisNanoprobesQuantum dots

Identifiers

PMID22969208
PMCPMC3436060
OpenAlexW2117729214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.